News

Battelle develops diagnostic test for COVID-19 with Ohio State University

Battelle and the Ohio State University Wexner Medical Center have joined forces to develop a diagnostic test for COVID-19.

The new rapid test will allow for faster turnaround time with results available in as few as five hours. Wexner Medical Center will administer the new test under its existing FDA certification permits. Ohio State processed its first 91 tests for diagnosis this week using Battelle and Ohio State equipment in a Centers for Medicare & Medicaid Services (CMS)-certified pathology lab at Ohio State.

Battelle is now working to bring a second lab online in hopes of making more test processing available.

“Ohio State and Battelle teams have shown incredible leadership and ingenuity, in moving this project forward so rapidly,” Ohio Governor Mike DeWine said. “With this collaboration, we will increase testing right here in Ohio to better help health care professionals and public health officials understand, treat, and prevent the spread of the virus.”

The system can process approximately 200 tests per day right now, but the goal is to process more than 1,000 test swabs per day.

“Battelle has decades of experience in infectious disease research and has worked with virtually all federal health and national security agencies to respond to emerging health threats,” Lou Von Thaer, Battelle’s president and CEO, said. “I am incredibly proud of the Battelle team, the speed at which it was able to work around the clock to quickly get this operational, and our collaboration with The Ohio State University.”

Battelle has the largest private BSL-3 laboratory in the country. The company is actively working on several other solutions related to the COVID-19 pandemic.

“We’re proud of the partnership of our dedicated scientists with Battelle researchers to help find innovative solutions for the coronavirus pandemic sweeping the world,” Hal Paz, executive vice president and chancellor for Health Affairs at The Ohio State University and CEO of the Ohio State Wexner Medical Center, said. “Our physicians and nurses are eager to start administering these tests that will greatly increase our capacity to diagnose more people and assist us in finding solutions for this disease. Testing is just one of more than 50 new research areas aimed at combatting COVID-19 underway at the Wexner Medical Center. We are working hand in hand with Battelle on many of these critical projects.”

Dave Kovaleski

Recent Posts

National security upgrades, pay raises and more pushed in Servicemember Quality of Life Improvement Act

Members of Congress recently paraded a mix of recommended updates to benefit military service members…

5 hours ago

Embattled TikTok in jeopardy as President Biden signs legislative ban

The ByteDance-owned TikTok faces an uphill battle in the United States after President Joe Biden…

3 days ago

Raytheon begins $115M expansion of Alabama missile integration facility

Promising to grow space for integrating and delivering on critical defense programs by more than…

3 days ago

Reward offered for Iranian nationals charged over multi-year cyber campaign against U.S. companies

In unsealing a 13-page indictment this week, the U.S. Department of Justice (DOJ) revealed charges…

4 days ago

FEND OFF Fentanyl Act included in national security supplemental

A bill targeting the illicit fentanyl supply chain, the Fentanyl Eradication and Narcotics Deterrence (FEND)…

4 days ago

Pennsylvania earns $10M federal grant to improve crime statistics reporting

In order to move the state closer to federal standards and allow reporting of local…

5 days ago

This website uses cookies.